Global mRNA Vaccines & Therapeutics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 95

Published Date: 25 Nov 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global mRNA Vaccines & Therapeutics size is estimated to be   million in 2021 from USD  million in 2020, with a change of  % between 2020 and 2021. The global mRNA Vaccines & Therapeutics market size is expected to grow at a CAGR of -44.3% for the next five years.

Market segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Infectious Disease Vaccines
    Cancer Vaccines

Market segment by Application can be divided into
    Infectious Disease
    Cancer

The key market players for global mRNA Vaccines & Therapeutics market are listed below:
    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics from 2019 to 2021.
Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 mRNA Vaccines & Therapeutics Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Infectious Disease Vaccines
        1.2.3 Cancer Vaccines
    1.3 Market Analysis by Application
        1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Infectious Disease
        1.3.3 Cancer
    1.4 Global mRNA Vaccines & Therapeutics Market Size & Forecast
        1.4.1 Global mRNA Vaccines & Therapeutics Sales in Value (2016-2026))
        1.4.2 Global mRNA Vaccines & Therapeutics Sales in Volume (2016-2026)
        1.4.3 Global mRNA Vaccines & Therapeutics Price by Type (2016-2026) & (USD/Doses)
    1.5 Global mRNA Vaccines & Therapeutics Production Capacity Analysis
        1.5.1 Global mRNA Vaccines & Therapeutics Total Production Capacity (2016-2026)
        1.5.2 Global mRNA Vaccines & Therapeutics Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 mRNA Vaccines & Therapeutics Market Drivers
        1.6.2 mRNA Vaccines & Therapeutics Market Restraints
        1.6.3 mRNA Vaccines & Therapeutics Trends Analysis

2 Manufacturers Profiles
    2.1 Moderna Therapeutics
        2.1.1 Moderna Therapeutics Details
        2.1.2 Moderna Therapeutics Major Business
        2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
        2.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 CureVac
        2.2.1 CureVac Details
        2.2.2 CureVac Major Business
        2.2.3 CureVac mRNA Vaccines & Therapeutics Product and Services
        2.2.4 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Translate Bio
        2.3.1 Translate Bio Details
        2.3.2 Translate Bio Major Business
        2.3.3 Translate Bio mRNA Vaccines & Therapeutics Product and Services
        2.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 BioNTech
        2.4.1 BioNTech Details
        2.4.2 BioNTech Major Business
        2.4.3 BioNTech mRNA Vaccines & Therapeutics Product and Services
        2.4.4 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Sangamo Therapeutics
        2.5.1 Sangamo Therapeutics Details
        2.5.2 Sangamo Therapeutics Major Business
        2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
        2.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Argos Therapeutics
        2.6.1 Argos Therapeutics Details
        2.6.2 Argos Therapeutics Major Business
        2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
        2.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 In-Cell-Art
        2.7.1 In-Cell-Art Details
        2.7.2 In-Cell-Art Major Business
        2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
        2.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 eTheRNA
        2.8.1 eTheRNA Details
        2.8.2 eTheRNA Major Business
        2.8.3 eTheRNA mRNA Vaccines & Therapeutics Product and Services
        2.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Ethris
        2.9.1 Ethris Details
        2.9.2 Ethris Major Business
        2.9.3 Ethris mRNA Vaccines & Therapeutics Product and Services
        2.9.4 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Tiba Biotechnology
        2.10.1 Tiba Biotechnology Details
        2.10.2 Tiba Biotechnology Major Business
        2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
        2.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 mRNA Vaccines & Therapeutics Sales by Manufacturer
    3.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in mRNA Vaccines & Therapeutics
    3.4 Market Concentration Rate
        3.4.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share
        3.4.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share
    3.5 Global mRNA Vaccines & Therapeutics Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and mRNA Vaccines & Therapeutics Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global mRNA Vaccines & Therapeutics Market Size by Region
        4.1.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Region (2016-2026)
        4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2026)
    4.2 North America mRNA Vaccines & Therapeutics Revenue (2016-2026)
    4.3 Europe mRNA Vaccines & Therapeutics Revenue (2016-2026)
    4.4 Asia-Pacific mRNA Vaccines & Therapeutics Revenue (2016-2026)
    4.5 South America mRNA Vaccines & Therapeutics Revenue (2016-2026)
    4.6 Middle East and Africa mRNA Vaccines & Therapeutics Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Type (2016-2026)
    5.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    5.3 Global mRNA Vaccines & Therapeutics Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Application (2016-2026)
    6.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    6.3 Global mRNA Vaccines & Therapeutics Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America mRNA Vaccines & Therapeutics Sales by Type (2016-2026)
    7.2 North America mRNA Vaccines & Therapeutics Sales by Application (2016-2026)
    7.3 North America mRNA Vaccines & Therapeutics Market Size by Country
        7.3.1 North America mRNA Vaccines & Therapeutics Sales in Volume by Country (2016-2026)
        7.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2026)
    8.2 Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2026)
    8.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
        8.3.1 Europe mRNA Vaccines & Therapeutics Sales in Volume by Country (2016-2026)
        8.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2016-2026)
    9.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2016-2026)
    9.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region
        9.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America mRNA Vaccines & Therapeutics Sales by Type (2016-2026)
    10.2 South America mRNA Vaccines & Therapeutics Sales by Application (2016-2026)
    10.3 South America mRNA Vaccines & Therapeutics Market Size by Country
        10.3.1 South America mRNA Vaccines & Therapeutics Sales in Volume by Country (2016-2026)
        10.3.2 South America mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2026)
    11.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2026)
    11.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country
        11.3.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 mRNA Vaccines & Therapeutics Typical Distributors
    12.3 mRNA Vaccines & Therapeutics Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global mRNA Vaccines & Therapeutics Revenue by Type, (USD Million), 2021-2026
    Table 2. Global mRNA Vaccines & Therapeutics Revenue by Application, (USD Million), 2021-2026
    Table 3. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 4. Moderna Therapeutics Major Business
    Table 5. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
    Table 6. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. CureVac Basic Information, Manufacturing Base and Competitors
    Table 8. CureVac Major Business
    Table 9. CureVac mRNA Vaccines & Therapeutics Product and Services
    Table 10. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Translate Bio Basic Information, Manufacturing Base and Competitors
    Table 12. Translate Bio Major Business
    Table 13. Translate Bio mRNA Vaccines & Therapeutics Product and Services
    Table 14. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. BioNTech Basic Information, Manufacturing Base and Competitors
    Table 16. BioNTech Major Business
    Table 17. BioNTech mRNA Vaccines & Therapeutics Product and Services
    Table 18. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 20. Sangamo Therapeutics Major Business
    Table 21. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
    Table 22. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 24. Argos Therapeutics Major Business
    Table 25. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
    Table 26. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. In-Cell-Art Basic Information, Manufacturing Base and Competitors
    Table 28. In-Cell-Art Major Business
    Table 29. In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
    Table 30. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. eTheRNA Basic Information, Manufacturing Base and Competitors
    Table 32. eTheRNA Major Business
    Table 33. eTheRNA mRNA Vaccines & Therapeutics Product and Services
    Table 34. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Ethris Basic Information, Manufacturing Base and Competitors
    Table 36. Ethris Major Business
    Table 37. Ethris mRNA Vaccines & Therapeutics Product and Services
    Table 38. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 40. Tiba Biotechnology Major Business
    Table 41. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
    Table 42. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2019-2021e) & (M Doses)
    Table 44. Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 45. Market Position of Manufacturers in mRNA Vaccines & Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 46. Global mRNA Vaccines & Therapeutics Production Capacity by Company, (M Doses): 2020 VS 2021
    Table 47. Head Office and mRNA Vaccines & Therapeutics Production Site of Key Manufacturer
    Table 48. mRNA Vaccines & Therapeutics New Entrant and Capacity Expansion Plans
    Table 49. mRNA Vaccines & Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 50. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021e) & (M Doses)
    Table 51. Global mRNA Vaccines & Therapeutics Sales by Region (2021-2026) & (M Doses)
    Table 52. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021e) & (USD Million)
    Table 53. Global mRNA Vaccines & Therapeutics Revenue by Region (2021-2026) & (USD Million)
    Table 54. Global mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 55. Global mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 56. Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2021e) & (USD Million)
    Table 57. Global mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 58. Global mRNA Vaccines & Therapeutics Price by Type (2016-2021e) & (USD/Doses)
    Table 59. Global mRNA Vaccines & Therapeutics Price by Type (2021-2026) & (USD/Doses)
    Table 60. Global mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 61. Global mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 62. Global mRNA Vaccines & Therapeutics Revenue by Application (2016-2021e) & (USD Million)
    Table 63. Global mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 64. Global mRNA Vaccines & Therapeutics Price by Application (2016-2021e) & (USD/Doses)
    Table 65. Global mRNA Vaccines & Therapeutics Price by Application (2021-2026) & (USD/Doses)
    Table 66. North America mRNA Vaccines & Therapeutics Sales by Country (2016-2021e) & (M Doses)
    Table 67. North America mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses)
    Table 68. North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021e) & (USD Million)
    Table 69. North America mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 70. North America mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 71. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 72. North America mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 73. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 74. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021e) & (M Doses)
    Table 75. Europe mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses)
    Table 76. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021e) & (USD Million)
    Table 77. Europe mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 78. Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 79. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 80. Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 81. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 82. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2016-2021e) & (M Doses)
    Table 83. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2021-2026) & (M Doses)
    Table 84. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2016-2021e) & (USD Million)
    Table 85. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2021-2026) & (USD Million)
    Table 86. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 87. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 88. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 89. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 90. South America mRNA Vaccines & Therapeutics Sales by Country (2016-2021e) & (M Doses)
    Table 91. South America mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses)
    Table 92. South America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021e) & (USD Million)
    Table 93. South America mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 94. South America mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 95. South America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 96. South America mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 97. South America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 98. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021e) & (M Doses)
    Table 99. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses)
    Table 100. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021e) & (USD Million)
    Table 101. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 102. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2021e) & (M Doses)
    Table 103. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
    Table 104. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2021e) & (M Doses)
    Table 105. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
    Table 106. Direct Channel Pros & Cons
    Table 107. Indirect Channel Pros & Cons
    Table 108. mRNA Vaccines & Therapeutics Typical Distributors
    Table 109. mRNA Vaccines & Therapeutics Typical Customers
List of Figures
    Figure 1. mRNA Vaccines & Therapeutics Picture
    Figure 2. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
    Figure 3. Infectious Disease Vaccines
    Figure 4. Cancer Vaccines
    Figure 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020
    Figure 6. Infectious Disease
    Figure 7. Cancer
    Figure 8. Global mRNA Vaccines & Therapeutics Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
    Figure 9. Global mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026) & (USD Million)
    Figure 10. Global mRNA Vaccines & Therapeutics Sales (2016-2026) & (M Doses)
    Figure 11. Global mRNA Vaccines & Therapeutics Price by Type (2016-2026) & (USD/Doses)
    Figure 12. Global mRNA Vaccines & Therapeutics Production Capacity (2016-2026) & (M Doses)
    Figure 13. Global mRNA Vaccines & Therapeutics Production Capacity by Geographic Region: 2020 VS 2021
    Figure 14. mRNA Vaccines & Therapeutics Market Drivers
    Figure 15. mRNA Vaccines & Therapeutics Market Restraints
    Figure 16. mRNA Vaccines & Therapeutics Market Trends
    Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2020
    Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2020
    Figure 19. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 20. Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2020
    Figure 21. Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2020
    Figure 22. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2026)
    Figure 23. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 24. North America mRNA Vaccines & Therapeutics Revenue (2016-2026) & (USD Million)
    Figure 25. Europe mRNA Vaccines & Therapeutics Revenue (2016-2026) & (USD Million)
    Figure 26. Asia-Pacific mRNA Vaccines & Therapeutics Revenue (2016-2026) & (USD Million)
    Figure 27. South America mRNA Vaccines & Therapeutics Revenue (2016-2026) & (USD Million)
    Figure 28. Middle East & Africa mRNA Vaccines & Therapeutics Revenue (2016-2026) & (USD Million)
    Figure 29. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 30. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2026)
    Figure 31. Global mRNA Vaccines & Therapeutics Price by Type (2016-2026) & (USD/Doses)
    Figure 32. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 33. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2026)
    Figure 34. Global mRNA Vaccines & Therapeutics Price by Application (2016-2026) & (USD/Doses)
    Figure 35. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 36. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 37. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2026)
    Figure 38. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 39. United States mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 40. Canada mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Mexico mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 43. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 44. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2026)
    Figure 45. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 46. Germany mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. France mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. United Kingdom mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Russia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Italy mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2026)
    Figure 52. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 53. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 55. China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Australia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. South America mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 62. South America mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 63. South America mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2026)
    Figure 64. South America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 65. Brazil mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Argentina mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 68. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 69. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2026)
    Figure 70. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Egypt mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Sales Channel: Direct Channel vs Indirect Channel
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Related Reports

Global mRNA Vaccines & Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global mRNA Vaccines & Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Pharma & Healthcare

The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global mRNA Vaccines & Therapeutics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global mRNA Vaccines & Therapeutics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Product Tags

mrna vaccines therapeutics

mRNA Vaccines & Therapeutics

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>